Skip to content
Review Open access

Mechanism of detection breast cancer using biosensors based on non-coding RNA

Aug 2026 · Discover Oncology · 0 citations

TL;DR

This review provides a focused overview of recent advancements in ncRNA-targeted biosensing interfaces, evaluating their operational frameworks and challenges regarding breast cancer diagnosis and monitoring.

Abstract

Breast cancer is the second most frequent malignancy in women and the fifth primary cause of cancer mortality globally. Although early identification and detection of breast cancer has resulted in decreased death rates, further breakthroughs in prevention, detection, and therapy are needed to enhance results and survival for women suffering from breast cancer, and also to provide a personalized therapeutic strategy Aside from the approximately 2% of the human genome that encodes proteins, a significant portion consists of non-coding RNA (ncRNA) which encompasses microRNAs (miRNAs), long non-coding RNAs (lncRNAs), circular RNA (circRNA), small nucleolar RNA (snoRNA), and PIWI-interacting RNAs (piRNA). So far, a substantial number of ncRNAs have been discovered and shown to be dysregulated in different forms of cancer, like breast cancer. Various modalities for detecting non-coding RNAs (ncRNAs) have been developed, including conventional northern blotting, microarrays, and reverse transcription-quantitative PCR (RT-qPCR). To overcome the structural constraints of these traditional methods, biosensor technologies have emerged as alternative platforms for the non-invasive, sensitive, and rapid quantification of oncogenic ncRNAs. Depending on the signal-transduction mechanism, these platforms are primarily categorized into electrochemical, optical, and field-effect transistor (FET)-based biosensors. This review provides a focused overview of recent advancements in ncRNA-targeted biosensing interfaces, evaluating their operational frameworks and challenges regarding breast cancer diagnosis and monitoring.

Read PDF

Similar papers

Review Open access Oct 2026

Exploring non-coding RNAs in Prostate Cancer: from Biomarkers to Therapeutic Strategies

Prostate cancer (PCa) is the second most prevalent malignancy and a leading cause of can- cer-related mortality in males worldwide. Despite advancements in therapeutic strategies, such as radical prostatectomy, radiotherapy, androgen deprivation therapy (ADT), and chemotherapy, treatment outcomes for metastatic castrat...

Dharanidharan Dhanabalan, N. Shanmugam · 0 citations
Review Aug 2026

Electrochemical biosensing of non-coding RNAs for prostate Cancer diagnosis and prognosis.

The present review focuses on the significance of ncRNAs as diagnostic markers for PCa and summarizes recent progress in biosensing technologies, emphasizing electrochemical methods designed to identify ncRNAs associated with this cancer.

Zahra Oushyani Roudsari, Asma Vafadar, F. Altalbawy et al. · 0 citations
Review Open access Sep 2026

Circular RNAs in Plasma and Beyond: Potential Biomarkers for Breast Cancer

This work consolidates recent advances in circRNA research across preoperative, postoperative, drug resistance, and recurrence settings, providing a framework for non-invasive diagnosis, clinical decision-making, and outcome prediction in BC management.

Chun-Ming Wang, Xu Wang, Yu-Bo Liu et al. · 0 citations
Review Open access Sep 2026

Machine learning approaches for cancer prognosis and diagnosis via non-coding RNA: a comprehensive review

This review critically evaluates ML-driven frameworks for cancer diagnosis and prognosis across four ncRNA subclasses, namely miRNAs, lncRNAs, circRNAs, and piRNAs, while also acknowledging the biophysical and thermodynamic models that reinforce ncRNA bioinformatics.

Md Shafayet Hossain, Yi-ping Phoebe Chen · 0 citations
2026

Large Language Models for Non-Coding RNA Biomarker Discovery in Breast Cancer.

This chapter explores the integration of LLMs with ncRNA biology, focusing on circRNAs, snoRNAs, and piRNAs in BC, and proposes a computational framework for biomarker identification.

Tamizhini Loganathan · 0 citations
Review Open access Sep 2026

Multi-omics and molecular biomarkers in breast cancer: a comprehensive review of diagnostic, prognostic, and predictive applications.

An overview of recent progress in multi-omics approaches is provided and significant miRNA-, lncRNA-, and exosome-related biomarkers associated with the initiation, progression, and therapeutic response of breast cancer are emphasized.

Kamyar Bagheri, Amirhossein Saberi, Maryam Zand et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.